Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: de Gruijl, Tanja D, Koster, Bas D, van den Hout, Mari FCM, Sluijter, Berbel JR, Molenkamp, Barbara G, Vuylsteke, Ronald JCLM, van Leeuwen, Paul AM, Scheper, Rik J, van den Tol, Petrousjka, van den Eertwegh, Alfons
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Poster Presentation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4649384/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-1426-3-S2-P201
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados